Cricoarytenoid arthritis in ankylosing spondylitis.

J. Wojtulewski,R. Sturrock,A. Branfoot,F. Hart
DOI: https://doi.org/10.1136/bmj.3.5872.145
1973-07-21
British Medical Journal
Abstract:The reintroduction of intrauterine contraceptive devices in the early 1960's was initially followed by widespread enthusiasm and then growing dissatisfaction. The pregnancy and expulsion rates were higher than expected and side effects of pain or bleeding or both necessitated a high pr,oportion of removals. The evidence suggested that a local endometrial action manifesting as a macrophage response, presumably chemotactically induced, prevented conception (Sagiroglu and Sagiroglu, 1970; Sedlis and Reyniak, 1970). Davis (1971) then postulated his surface interaction hypothesis that the antifertility effect of an inert I.U.D. bore a direct relation to the surface area of contact between the I.U.D. and the endometrium. Bearing these two points in mind the Dalkon Shield was developed by Davis, a gynaecologist, and Lerner, a bioengineer. Clinical trials conducted by Davis and his associates have been most enthusiastic (Davis, 1971). This study, however, has shown a much higher complication rate than that reported by Davis. The pregnancy rate for example is much albove that of 11/100 users at 12 months of use and corresponds more to the 3-8/100 users after one year found in the multicentre U.K. study reported by the Family Planning Research Unit of the University of Exeter (Snowden and Williams, 1973) in which there is no information about the number of women who used a spermicide in addition to the Shield. In the present report about 5 % of participants who asked to use a spermicide did so intermittently. The expulsion rate of 6 3/100 users in a year is again greater than the 2-3/100 users at 12 months reported by Davis (1971). This rate, however, is much lower than the expulsion rates ascribed to the more generally used I.U.D.s such as the Lippes Loop C and the Saf-T-Coil of 19 and Lippes Loop D of 12-7/100 users at 12 months' use (Kleinman, 1972). The figures for medical removal rates will be greatly influenced by individual doctors' attitudes to this particular problem. Nevertheless our rate corresponds closely to that of 9-7/100 users at one year reported by Ostergard and Broen (1971) and is approaching the removal rates of 11-0/100 users at one year for the Lippes Loop (Tietze and Levit, 1970). The Exeter survey reported a much lower removal rate for the Shield (4-6/100 users at one year), while the figures of Davis again are the lowest recorded at 2/100 users at one year. The continuation rate of 69% at our clinic after one year of use again puts the Dalkon Shield on a par with more conventional I.U.D.s (Kleinman, 1972).
What problem does this paper attempt to address?